🔎 Trials Near Me

Home › Glioblastoma › Ohio › Cincinnati

Glioblastoma clinical trials in Cincinnati, OH

6 studies for Glioblastoma are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

RecruitingPhase 1/2
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05432804

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RecruitingEarly phase 1Healthy volunteers welcome
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RecruitingPhase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Cincinnati
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Glioblastoma trials in other cities

Other studies in Cincinnati

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.